Factors Contributing to Underutilization of Epinephrine for Allergy Anaphylaxis

Overview

About this study

The purpose of this study is to evaluate the rate of compliance for having an emergency epinephrine autoinjector readily accessible in adults with allergies, and to determine factors that negatively influence adults with allergies for having an emergency epinephrine autoinjector readily accessible.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Please contact the study team to discuss whether or not you are eligible to participate in a study.

Inclusion Criteria:

  • Adults who are participating in the Mayo Clinic Biobank that have identified themselves as having an allergy as queried on question #20 on the Biobank questionnaire.

Exclusion Criteria: 

  • Patient refusal to participate in research studies at Mayo Clinic.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Thanai Pongdee, M.D.

Contact us for the latest status

Contact information:

Anna Harrell

(904)953-8183

Harrell.Anna@mayo.edu

Rochester, Minn.

Mayo Clinic principal investigator

Thanai Pongdee, M.D.

Contact us for the latest status

Contact information:

Mayo Clinic Biobank

(866) 613-2386

biobank@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available